We are live on ! Find out more
MC

Mayo Clinic Portfolio holdings

AUM $2.9M
1-Year Est. Return 14.49%
This Fund
S&P 500
This Quarter Est. Return
+49.04%
1 Year Est. Return
+14.49%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$105M
AUM Growth
+$65M
Cap. Flow
+$42.9M
Cap. Flow %
41.05%
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
–
Reduced
1
Closed
1
Avg Time Held
1.6 quarters
Top 10 Avg Time Held
1.6 quarters
Top 20 Avg Time Held
1.6 quarters

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$26.5M
2
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$17M

Top Sells

Rank Stock Value
1
STEX icon
Streamex Corp
STEX
+$402K
2
EXAS icon
Exact Sciences
EXAS
+$220K

Sector Composition

Rank Sector Weight
1 Healthcare 36.65%
2 Energy 35.52%
3 Miscellaneous 26.76%
4 Financials 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BSM icon
1
Black Stone Minerals
BSM
$3.16B
$37.1M 35.52%
5,711,137
– –
2019 Q4
2 quarters
SPY icon
2
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$28M 26.76%
+90,686
New +$26.5M
2020 Q2
0 quarters
ZNTL icon
3
Zentalis Pharmaceuticals
ZNTL
$239M
$21.3M 20.34%
+442,713
New +$17M
2020 Q2
0 quarters
UBX icon
4
DELISTED
Unity Biotechnology
UBX
$13.6M 13.06%
157,198
– –
2019 Q4
2 quarters
EVLO
5
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$2.38M 2.27%
24,248
– –
2019 Q4
2 quarters
STEX icon
6
Streamex Corp
STEX
$56.4M
$1.13M 1.08%
15,638
-4,620
-23% -$402K
2019 Q4
2 quarters
MCRB icon
7
Seres Therapeutics
MCRB
$26.9M
$857K 0.82%
9,000
– –
2019 Q4
2 quarters
CLPT icon
8
ClearPoint Neuro
CLPT
$311M
$168K 0.16%
47,148
– –
2019 Q4
2 quarters
VYNT
9
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$1K ﹤0.01%
89
– –
2019 Q4
2 quarters
EXAS icon
10
DELISTED
Exact Sciences
EXAS
– –
-3,795
Closed -$220K –

Similar funds

SWS
SYSTM Wealth Solutions Chicago, Illinois $3.29M AUM 31.67% 1-Year Est. Return
PWA
Pillar Wealth Advisors West Chester, Pennsylvania $3.35M AUM 22.3% 1-Year Est. Return
CU
Cornell University New York $3.44M AUM 9.69% 1-Year Est. Return
QC
QCM Cayman Houston, Texas $3.63M AUM 61.13% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return
JC
Jetstream Capital Brentwood, Tennessee $1.37M AUM
MIG
MGG Investment Group New York $1.36M AUM 20.76% 1-Year Est. Return

Mayo Clinic's Q2 2020 Portfolio in Review

As of Q2 2020, Mayo Clinic held 10 positions worth $105M, up 164% from $39.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Mayo Clinic deployed $42.9M of net new capital in Q2 2020, opening 2 new positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 90,686 shares worth $28M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 30% a quarter earlier, followed by Energy and Miscellaneous.

On the sell side, the largest reduction was Streamex Corp, an estimated $402K trimmed.

  • Mayo Clinic's largest Q2 2020 buy was State Street SPDR S&P 500 ETF Trust: 90,686 shares worth $28M.
  • Mayo Clinic's biggest Q2 2020 reduction was Streamex Corp, cutting an estimated $402K.
  • Mayo Clinic fully exited Exact Sciences in Q2 2020, selling an estimated $220K.
  • Mayo Clinic's ten largest holdings make up 100% of its $105M portfolio in Q2 2020.
  • Mayo Clinic opened 2 new positions and closed 1 in Q2 2020.
  • Mayo Clinic's portfolio value rose 164% quarter-over-quarter to $105M.

Based on Mayo Clinic's 13F filing for Q2 2020, filed 13 Aug 2020.